- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Huntington Disease"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Huntington Disease" (39 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03342053 | Not yet recruiting | Study in Huntington's Disease Patients Who Participated in Prior Investigational Studies of ISIS 443139 |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
46 | All | 25 Years and older (Adult, Senior) | NCT03342053 | ISIS 443139-CS2 | November 2017 | September 30, 2019 | September 30, 2019 | November 14, 2017 | November 27, 2017 |
|
||
2 | NCT03252535 | Not yet recruiting | Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
35 | All | 21 Years to 65 Years (Adult) | NCT03252535 | ADORE-DH 52375916.1.0000.5412 |
ADORE-DH | April 15, 2018 | April 15, 2020 | September 30, 2020 | August 17, 2017 | August 17, 2017 | ||
3 | NCT02728115 | Not yet recruiting | Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease |
|
|
Interventional | Phase 1 |
|
Industry / Other |
|
|
6 | Male | 21 Years to 65 Years (Adult) | NCT02728115 | SAVE-DH 51005115.9.0000.5412 |
SAVE-DH | October 2017 | October 2022 | February 2023 | April 5, 2016 | August 16, 2017 | ||
4 | NCT02535884 | Recruiting | Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD) |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT02535884 | KKS-198 DRKS00006785 |
HD-DBS | July 2014 | June 30, 2020 | October 31, 2020 | August 31, 2015 | September 25, 2017 |
|
|
5 | NCT02990676 | Recruiting | Exploring Computerised Cognitive Training for People With Huntington's Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT02990676 | 1535-16 HF-16-1152 210821 |
CogTrainHD | January 25, 2017 | September 2019 | September 2019 | December 13, 2016 | January 30, 2018 |
|
|
6 | NCT03296176 | Recruiting | Metabolomic Study in Huntington's Disease (METABO-HD) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
150 | All | 20 Years to 70 Years (Adult, Senior) | NCT03296176 | 49RC17_0086 | October 9, 2017 | September 2019 | September 2019 | September 28, 2017 | November 1, 2017 |
|
||
7 | NCT02336633 | Recruiting | Resveratrol and Huntington Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
102 | All | 18 Years and older (Adult, Senior) | NCT02336633 | P130918 | REVHD | July 2015 | January 2019 | January 2019 | January 13, 2015 | April 17, 2018 |
|
|
8 | NCT01860339 | Recruiting | Growth and Development of the Striatum in Huntington's Disease |
|
Observational |
|
Other / NIH |
|
|
400 | All | 6 Years to 18 Years (Child, Adult) | NCT01860339 | 200507759 4R01NS055903-08 |
Kids-HD | July 2005 | August 2018 | May 22, 2013 | June 1, 2017 |
|
||||
9 | NCT03034122 | Recruiting | Is Caffeine an Environmental Modifier in Huntington's Disease? |
|
Observational |
|
Other |
|
|
100 | All | 21 Years and older (Adult, Senior) | NCT03034122 | 2015_67 2016-A00892-49 |
CrEAM-HD | October 11, 2017 | October 2021 | October 2021 | January 27, 2017 | December 22, 2017 |
|
|||
10 | NCT03417583 | Not yet recruiting | Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
100 | All | 21 Years and older (Adult, Senior) | NCT03417583 | 172030 | May 2018 | May 2021 | May 2021 | January 31, 2018 | March 27, 2018 |
|
||
11 | NCT03344601 | Recruiting | PHysical Activity and Exercise Outcomes in Huntington's Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
120 | All | 18 Years and older (Adult, Senior) | NCT03344601 | SPON 1631-17 | PACE-HD | February 16, 2018 | October 16, 2019 | December 31, 2019 | November 17, 2017 | March 6, 2018 |
|
|
12 | NCT03119246 | Recruiting | Beta Testing of a New Assessment in Huntington's Disease (HD) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT03119246 | P150201 | CAPIT-HD Beta | June 2016 | March 2018 | March 2018 | April 18, 2017 | April 18, 2017 |
|
|
13 | NCT03225846 | Recruiting | Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
48 | All | 25 Years to 65 Years (Adult) | NCT03225846 | WVE-HDSNP2-001 | PRECISION-HD2 | July 17, 2017 | September 2019 | September 2019 | July 21, 2017 | March 27, 2018 |
|
|
14 | NCT03225833 | Recruiting | Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
48 | All | 25 Years to 65 Years (Adult) | NCT03225833 | WVE-HDSNP1-001 | PRECISION-HD1 | July 17, 2017 | September 2019 | September 2019 | July 21, 2017 | March 27, 2018 |
|
|
15 | NCT01879267 | Recruiting | Exercise Effects in Huntington's Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | Male | 30 Years to 60 Years (Adult) | NCT01879267 | KEK-ZH-Nr. 2009-0119 | January 2012 | January 2018 | January 2018 | June 17, 2013 | July 19, 2017 |
|
||
16 | NCT02639871 | Recruiting | Dynamic Neuroimaging Biomarkers in Huntington's Disease |
|
Observational |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT02639871 | P140708 2015-A00793-46 |
HDeNERGY | June 28, 2016 | June 2018 | September 2018 | December 28, 2015 | November 30, 2017 |
|
|||
17 | NCT02855476 | Recruiting | HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease |
|
Observational |
|
Other |
|
|
600 | All | 21 Years to 75 Years (Adult, Senior) | NCT02855476 | 15/0519 | HDClarity | January 2017 | July 2019 | July 2020 | August 4, 2016 | March 19, 2018 |
|
|||
18 | NCT02956148 | Recruiting | Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
45 | All | 18 Years to 73 Years (Adult, Senior) | NCT02956148 | CHDIKI1401 | LONGPDE10 | June 2015 | June 2018 | September 2018 | November 7, 2016 | November 7, 2016 |
|
|
19 | NCT02481674 | Recruiting | VX15/2503 Treatment for Huntington's Disease |
|
|
Interventional | Phase 2 |
|
Industry / Other |
|
|
240 | All | 21 Years and older (Adult, Senior) | NCT02481674 | VX15/2503-N-131 | SIGNAL | July 2015 | May 2020 | May 2020 | June 25, 2015 | October 13, 2017 |
|
|
20 | NCT02453061 | Recruiting | A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT02453061 | C14-62 | TRIHEP3 | June 2015 | June 2017 | June 2019 | May 25, 2015 | March 9, 2017 |
|
|
21 | NCT02263430 | Not yet recruiting | PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease |
|
|
Interventional | Not Applicable |
|
Industry / Other |
|
|
8 | All | 18 Years and older (Adult, Senior) | NCT02263430 | PINS-007 | December 2016 | December 2018 | December 2018 | October 13, 2014 | October 14, 2016 | |||
22 | NCT01412125 | Recruiting | Study of Biomarkers That Predict the Evolution of Huntington's Disease |
|
|
Observational |
|
Other |
|
|
1800 | All | 18 Years and older (Adult, Senior) | NCT01412125 | P090302 | BIOHD | September 2003 | January 2021 | January 2021 | August 9, 2011 | October 9, 2014 |
|
||
23 | NCT02509793 | Recruiting | A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
20 | All | 18 Years to 80 Years (Adult, Senior) | NCT02509793 | Pro00013929 HSC-MS-13-0878 |
April 2014 | July 2018 | July 2018 | July 28, 2015 | August 11, 2017 |
|
||
24 | NCT03019289 | Recruiting | A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
38 | Male | 25 Years and older (Adult, Senior) | NCT03019289 | TV7820-IMG-10082 2016-001757-41 |
March 20, 2017 | December 21, 2017 | January 24, 2018 | January 12, 2017 | December 18, 2017 |
|
||
25 | NCT02507284 | Recruiting | Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry / NIH / Other |
|
|
108 | All | 18 Years and older (Adult, Senior) | NCT02507284 | AVN011 1U44NS090616-01A1 |
June 2016 | June 2018 | June 2018 | July 23, 2015 | July 2, 2017 |
|
||
26 | NCT03193099 | Recruiting | Decoding Presymptomatic White Matter Changes in Huntington Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT03193099 | C16-115 2017-A00589-44 |
Win-HD | July 11, 2017 | December 30, 2018 | December 30, 2018 | June 20, 2017 | August 29, 2017 |
|
|
27 | NCT03434548 | Not yet recruiting | iMarkHD: In Vivo Longitudinal Imaging of HD Pathology |
|
Observational |
|
Other |
|
|
150 | All | 21 Years to 75 Years (Adult, Senior) | NCT03434548 | C-000917-1 | April 1, 2018 | March 31, 2024 | March 31, 2024 | February 15, 2018 | February 15, 2018 | |||||
28 | NCT03306888 | Recruiting | Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
14 | All | 18 Years to 65 Years (Adult) | NCT03306888 | 546845 | October 10, 2017 | June 10, 2018 | June 10, 2018 | October 11, 2017 | December 5, 2017 |
|
||
29 | NCT01884181 | Recruiting | Accelerated Diffusion MRI for Diagnosis of Hungtington Disease |
|
Observational |
|
Other |
|
|
80 | All | 20 Years to 70 Years (Adult, Senior) | NCT01884181 | 102-1056B | January 2014 | December 2017 | December 2017 | June 21, 2013 | August 4, 2016 |
|
||||
30 | NCT00313495 | Recruiting | Cooperative Huntington's Observational Research Trial |
|
Observational |
|
Other |
|
5000 | All | Child, Adult, Senior | NCT00313495 | COHORT | February 2006 | December 2020 | December 2020 | April 12, 2006 | March 7, 2011 |
|
|||||
31 | NCT03421327 | Recruiting | Genetic Risk: Whether, When, and How to Tell Adolescents |
|
Observational |
|
Other / NIH |
|
|
100 | All | 15 Years and older (Child, Adult, Senior) | NCT03421327 | IRB00121662 R01HG008045 |
September 1, 2017 | December 31, 2018 | December 31, 2018 | February 5, 2018 | February 5, 2018 |
|
||||
32 | NCT02819700 | Recruiting | Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI) |
|
|
Observational |
|
Other |
|
|
285 | All | 40 Years to 85 Years (Adult, Senior) | NCT02819700 | PI11-PR-GODEFROY-2 | ISDC | January 2013 | December 2017 | December 2017 | June 30, 2016 | June 30, 2016 |
|
||
33 | NCT03297177 | Recruiting | Autologous Stem/Stromal Cells in Neurological Disorders and Disease |
|
|
Interventional | Not Applicable |
|
Industry / Other |
|
|
300 | All | 18 Years to 90 Years (Adult, Senior) | NCT03297177 | GARM NDD | NDD | December 29, 2017 | January 1, 2023 | January 1, 2023 | September 29, 2017 | January 23, 2018 |
|
|
34 | NCT03052712 | Recruiting | Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies (GREFEX II) |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1170 | All | 20 Years to 80 Years (Adult, Senior) | NCT03052712 | PI2015_843_0031 | GREFEXII | November 13, 2015 | November 13, 2018 | November 13, 2018 | February 14, 2017 | February 14, 2017 |
|
|
35 | NCT02750982 | Recruiting | Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT02750982 | TRBROWN201601 | July 2016 | August 2018 | December 2018 | April 26, 2016 | January 23, 2018 |
|
||
36 | NCT02252380 | Recruiting | ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
10 | All | 18 Years to 85 Years (Adult, Senior) | NCT02252380 | MD003 | May 2015 | December 2018 | December 2018 | September 30, 2014 | March 27, 2018 |
|
||
37 | NCT03087526 | Not yet recruiting | NIPD on CFTC for Triplet Repeat Diseases |
|
|
Interventional | Not Applicable |
|
Other |
|
|
55 | Female | 18 Months and older (Child, Adult, Senior) | NCT03087526 | UF9790 | DIACCIMEX | April 1, 2017 | April 30, 2019 | October 31, 2019 | March 22, 2017 | March 22, 2017 | ||
38 | NCT01931644 | Recruiting | Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More) |
|
Observational |
|
Industry |
|
|
20000 | All | 18 Years to 100 Years (Adult, Senior) | NCT01931644 | SAN-BB-01 | July 2013 | August 2020 | December 2040 | August 29, 2013 | April 18, 2018 |
|
||||
39 | NCT00874783 | Recruiting | Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases |
|
Observational |
|
Other |
|
120 | All | 18 Years and older (Adult, Senior) | NCT00874783 | 0599-08-HMO-CTIL | April 2009 | December 2025 | December 2025 | April 3, 2009 | November 28, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.